Back to results
US 2019/0175561 A1Published application
Heterocyclic compounds and their use in preventing or treating bacterial infections
AssigneeMutabilis
InventorsJulie BRIAS, Sophie CHASSET, Francis CHEVREUIL, Nicolas LECOINTE, Benoît LEDOUSSAL, Frédéric LE STRAT, Julien BARBION
Life of this patent
Estimating the term…
Abstract
The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as β-lactamase inhibitors and/or as antibacterial agents.
Claims23
1-18. (canceled)
A compound of formula (I)
- wherein:
- A-B represents
- a CH═CH double bond or
- a ring W, unsubstituted or substituted by one or more T, represents a phenyl group or a 5- or 6-membered aromatic heterocycle comprising at least one heteroatom selected from the group consisting of O, N, N(R3), S, S(O) or S(O)2;
- R1 represents a carbon-linked, unsubstituted or substituted by one or more T1, aromatic, totally or partially unsaturated, 5- or 6-membered heterocycle comprising at least one nitrogen atom;
- R2 represents SO3H, CFHCO2H or CF2CO2H;
- R3 independently represents hydrogen;
- —(CH2)m—CN;
- —(CH2)nOC(O)Q1;
- —(CH2)m—C(O)OQ1;
- —(CH2)n—OC(O)OQ1;
- —(CH2)n—OC(O)NQ1Q2;
- —(CH2)m—C(O)NQ1Q2;
- —(CH2)m—C(O)NQ1OQ2;
- —(CH2)m—C(O)NQ1-NQ1Q2;
- —(CH2)n—NQ1C(O)Q2;
- —(CH2)n—NQ1C(O)OQ2;
- —(CH2)n—NQ1C(O)NQ1Q2;
- —(CH2)nOQ1;
- —(CH2)nNQ1Q2;
- —(CH2)n—NH—C(NHQ3)=NQ4;
- —(CH2)n—NH—CH═NQ3;
- —(CH2)m—C(NHQ3)=NQ4;
- —(Y)—C1-C6-alkyl;
- —(Y)—C1-C6-fluoroalkyl;
- —(Y)—C3-C6-cycloalkyl;
- —(Y)—C3-C6-cyclofluoroalkyl;
- —(Y)—(CH2)p—CN;
- —(Y)—(CH2)pOC(O)Q1;
- —(Y)—(CH2)p—C(O)OQ1;
- —(Y)—(CH2)p—OC(O)OQ1;
- —(Y)—(CH2)p—OC(O)NQ1Q2;
- —(Y)—(CH2)p—C(O)NQ1Q2;
- —(Y)—(CH2)p—C(O)NQ1OQ2;
- —(Y)—(CH2)p—C(O)NQ1-NQ1Q2;
- —(Y)—(CH2)p—NQ1C(O)Q2;
- —(Y)—(CH2)p—NQ1C(O)OQ2;
- —(Y)—(CH2)pNQ1C(O)NQ1Q2;
- —(CH2)nOQ1;
- —(Y)—(CH2)pNQ1Q2;
- —(Y)—(CH2)p—NH—C(NHQ3)=NQ4;
- —(Y)—(CH2)p—NH—CH═NQ3;
- —(Y)—(CH2)p—C(NHQ3)=NQ4;
- or
- R3, unsubstituted or substituted by one or more T2, independently represents-C1-C6-alkyl;
- —C1-C6-fluoroalkyl;
- —C3-C6-cycloalkyl;
- —C3-C6-cyclofluoroalkyl;
- —(CH2)m-(aromatic, totally or partially unsaturated, 4- to 6-membered heterocycle comprising at least one nitrogen atom) or —(Y)—(CH2)m-(aromatic, totally or partially unsaturated, 4- to 6-membered heterocycle comprising at least one nitrogen atom);
- T and T1, identical or different, independently represent a fluorine atom;
- O—C1-C6-fluoroalkyl;
- —(CH2)m—C3-C6-cyclofluoroalkyl;
- —(CH2)m—CN;
- —(CH2)mOC(O)Q1;
- —(CH2)m—C(O)OQ1;
- —(CH2)m—OC(O)OQ1;
- —(CH2)m—OC(O)NQ1Q2;
- —(CH2)m—C(O)NQ1Q2;
- —(CH2)m—C(O)NQ1OQ2;
- —(CH2)m—C(O)NQ1-NQ1Q2;
- —(CH2)m—NQ1C(O)Q2;
- —(CH2)m—NQ1C(O)OQ2;
- —(CH2)m—NQ1C(O)NQ1Q2;
- —(CH2)mOQ1;
- —(CH2)mNQ1Q2;
- —(CH2)m—NH—C(NHQ3)=NQ4;
- —(CH2)m—NH—CH═NQ3;
- —(CH2)m—C(NHQ3)=NQ4;
- -(L)-(CH2)p—CN;
- -(L)-(CH2)nOC(O)Q1;
- -(L)-(CH2)p—C(O)OQ1;
- -(L)-(CH2)n—OC(O)OQ1;
- -(L)-(CH2)n—OC(O)NQ1Q2;
- -(L)-(CH2)p—C(O)NQ1Q2;
- -(L)-(CH2)p—C(O)NQ1OQ2;
- -(L)-(CH2)p—C(O)NQ-NQ1Q2;
- -(L)-(CH2)n—NQ1C(O)Q2;
- -(L)-(CH2)n—NQ1C(O)OQ2;
- -(L)-(CH2)n—NQ1C(O)NQ1Q2;
- -(L)-(CH2)nOQ1;
- -(L)-(CH2)nNQ1Q2;
- -(L)-(CH2)n—NH—C(NHQ3)=NQ4;
- -(L)-(CH2)n—NH—CH═NQ3;
- -(L)-(CH2)n—C(NHQ3)=NQ4;
- or
- T and T1, identical or different, unsubstituted or substituted by one or more T3, independently represent C1-C6-alkyl;
- C1-C6-fluoroalkyl;
- —(CH2)m—C3-C6-cycloalkyl;
- -(L)-C1-C6-alkyl;
- -(L)-C1-C6-fluoroalkyl;
- -(L)-C3-C6-cycloalkyl;
- -(L)-C3-C6-cyclofluoroalkyl;
- —(CH2)m-heterocycle;
- -(L)-(CH2)p-heterocycle;
- Q1 and Q2, identical or different, independently represent a hydrogen atom;
- —(CH2)nNHQ3;
- —(CH2)n—NH—C(NHQ3)=NQ4;
- (CH2)n—NH—CH═NQ3;
- (CH2)p—C(NHQ3)=NQ4;
- —(CH2)nOQ3;
- —(CH2)pCONHQ3;
- —(CH2)n—NHCONHQ3 or
- Q1 and Q2, identical or different, unsubstituted or substituted by one or more T3, independently represent a C1-C3-alkyl;
- —(CH2)m-(4-, 5- or 6-membered heterocycle);
- or Q1, Q2 and the nitrogen atom to which they are bonded, form an unsubstituted or substituted by one or more T3, saturated or partially unsaturated, 4-, 5- or 6-membered N comprising heterocycle optionally comprising 1, 2, or 3 further heteroatoms;
- Q3 and Q4, identical or different, independently represent a hydrogen atom or a C1-C3-alkyl;
- T2 and T3, identical or different, independently represent a fluorine atom;
- C1-C6-alkyl;
- C1-C6-fluoroalkyl;
- O—C1-C6-fluoroalkyl;
- —(CH2)m—C3-C6-cycloalkyl;
- —(CH2)m—C3-C6-cyclofluoroalkyl;
- —(CH2)m—CN;
- —(CH2)mOC(O)Q3;
- —(CH2)m—C(O)OQ3;
- —(CH2)m—OC(O)OQ3;
- —(CH2)m—OC(O)NQ3Q4;
- —(CH2)m—C(O)NQ3Q4;
- —(CH2)m—C(O)NQ3OQ4;
- —(CH2)m—C(O)NQ3-NQ3Q4;
- —(CH2)m—NQ3C(O)Q4;
- —(CH2)m—NQ3C(O)OQ4;
- —(CH2)m—NQ3C(O)NQ3Q4;
- —(CH2)mOQ1;
- —(CH2)mNQ3Q4;
- —(CH2)m—NH—C(NHQ3)=NQ4;
- —(CH2)m—NH—CH═NQ3;
- —(CH2)m—C(NHQ3)=NQ4;
- -(L)-(CH2)p—C3-C6-cycloalkyl;
- -(L)-(CH2)p—C3-C6-cyclofluoroalkyl;
- -(L)-(CH2)p—CN;
- -(L)-(CH2)nOC(O)Q3;
- -(L)-(CH2)p—C(O)OQ3;
- -(L)-(CH2)n—OC(O)OQ3;
- -(L)-(CH2)n—OC(O)NQ3Q4;
- -(L)-(CH2)p—C(O)NQ3Q4;
- -(L)-(CH2)p—C(O)NQ3OQ4;
- -(L)-(CH2)p—C(O)NQ3-NQ3Q4;
- -(L)-(CH2)n—NQ3C(O)Q4;
- -(L)-(CH2)n—NQ3C(O)OQ4;
- -(L)-(CH2)n—NQ3C(O)NQ3Q4;
- -(L)-(CH2)nOQ1;
- -(L)-(CH2)nNQ3Q4;
- -(L)-(CH2)n—NH—C(NHQ3)=NQ4;
- -(L)-(CH2)n—NH—CH═NQ3;
- -(L)-(CH2)n—C(NHQ3)=NQ4;
- Y, identical or different, independently represents C═O or S(O)2;
- L, identical or different, independently represents O, S, N(R3), S(O) or S(O)2;
- m independently represents 0, 1, 2, 3 or 4;
- n independently represents 2, 3 or 4;
- p independently represents 1, 2, 3 or 4 when Y is C═O or 2, 3 or 4 when Y is S(O)2;
- wherein
- any carbon atom present within a group selected from alkyl, cycloalkyl, fluoroalkyl, cyclofluoroalkyl and heterocycle can be oxidized to form a C═O group;
- any sulphur atom present within a heterocycle can be oxidized to form a S═O group or a S(O)2 group;
- any nitrogen atom present within a heterocycle or present within group wherein it is trisubstituted thus forming a tertiary amino group, can be further quaternized by a methyl group;
- and a pharmaceutically acceptable salt, a zwitterion, an optical isomer, a racemate, a diastereoisomer, an enantiomer, a geometric isomer or a tautomer thereof.
153 more elements
Dependencies are inferred from the claim text.